Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin - PubMed (original) (raw)
Comparative Study
Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin
S el Rouby et al. Clin Exp Immunol. 1992 Jul.
Abstract
Cyclosporin (CsA) is an immunosuppressant which binds to cyclophilin (Cyp). The relationship between Cyp binding and immunosuppression has been questioned since one of the analogs of CsA, N-methyl-L-alanyl6 cyclosporin (methyl-alanyl CsA) binds to Cyp but is not immunosuppressive. We compared the immunosuppressive properties of CsA, methyl-alanyl CsA and o-acetyl-threonine2 cyclosporin (monoacetyl CyC), since monoacetyl CyC does not bind to Cyp when tested in cell-free assays and its immunosuppressive properties had not been tested. Cyp is a peptidyl-prolyl isomerase which is abundant in all human tissues, yet the activities of CsA are mostly confined to inhibition of T cell and thymocyte activation, and to neuro- and nephro-toxicity and are independent of inhibition of the isomerase. Activation of thymocytes and of T cells is regulated by the binding of a nuclear factor(s) (NFs) to the NF-AT region (-285 to -255) of the IL-2 promoter. We studied inhibition of binding to the NF-AT region of NFs derived from primary cultures of thymocytes treated with CsA or its analogs. In addition, we compared the effect of CsA and its analogs on the expression of the IL-2 gene in a stably transfected Jurkat-cell line (Fgl 5) which contains three copies of NF-AT and the reporter enzyme beta-galactosidase; and on inhibition of proliferation induced by concanavalin A (Con A) or IL-2. We found that monoacetyl CyC which does not bind to Cyp is immunosuppressive by our criteria when tested in cultured cells due to either a different mechanism of action or to metabolic activation.
Similar articles
- Molecular mode of action of cyclosporin and FK506 in human thymocytes.
Reem GH. Reem GH. J Autoimmun. 1992 Apr;5 Suppl A:159-65. doi: 10.1016/0896-8411(92)90030-t. J Autoimmun. 1992. PMID: 1380243 - Molecular mechanisms of immunosuppression by cyclosporins.
Zenke G, Baumann G, Wenger R, Hiestand P, Quesniaux V, Andersen E, Schreier MH. Zenke G, et al. Ann N Y Acad Sci. 1993 Jun 23;685:330-5. doi: 10.1111/j.1749-6632.1993.tb35882.x. Ann N Y Acad Sci. 1993. PMID: 7689806 Review. - Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
Ke H, Mayrose D, Belshaw PJ, Alberg DG, Schreiber SL, Chang ZY, Etzkorn FA, Ho S, Walsh CT. Ke H, et al. Structure. 1994 Jan 15;2(1):33-44. doi: 10.1016/s0969-2126(00)00006-x. Structure. 1994. PMID: 8075981 - Molecular mechanisms of immunosuppression.
Baumann G, Zenke G, Wenger R, Hiestand P, Quesniaux V, Andersen E, Schreier MH. Baumann G, et al. J Autoimmun. 1992 Apr;5 Suppl A:67-72. doi: 10.1016/0896-8411(92)90021-h. J Autoimmun. 1992. PMID: 1380246 Review.
Cited by
- Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
Billich A, Hammerschmid F, Peichl P, Wenger R, Zenke G, Quesniaux V, Rosenwirth B. Billich A, et al. J Virol. 1995 Apr;69(4):2451-61. doi: 10.1128/JVI.69.4.2451-2461.1995. J Virol. 1995. PMID: 7884893 Free PMC article.
References
- Nature. 1991 Aug 29;352(6338):803-7 - PubMed
- Science. 1984 Jul 27;225(4660):429-30 - PubMed
- Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9483-7 - PubMed
- Cell. 1991 Aug 23;66(4):799-806 - PubMed
- Immunology. 1991 Mar;72(3):399-404 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources